ריבסטיגמין דקסל 1.5 מג إسرائيل - العبرية - Ministry of Health

ריבסטיגמין דקסל 1.5 מג

dexcel ltd, israel - rivastigmine as hydrogen tartrate - קפסולה קשיחה - rivastigmine as hydrogen tartrate 1.5 mg - rivastigmine

ריבסטיגמין דקסל 3 מג إسرائيل - العبرية - Ministry of Health

ריבסטיגמין דקסל 3 מג

dexcel ltd, israel - rivastigmine as hydrogen tartrate - קפסולה קשיחה - rivastigmine as hydrogen tartrate 3 mg - rivastigmine

ריבסטיגמין דקסל 4.5 מג إسرائيل - العبرية - Ministry of Health

ריבסטיגמין דקסל 4.5 מג

dexcel ltd, israel - rivastigmine as hydrogen tartrate - קפסולה קשיחה - rivastigmine as hydrogen tartrate 4.5 mg - rivastigmine

ריבסטיגמין דקסל 6 מג إسرائيل - العبرية - Ministry of Health

ריבסטיגמין דקסל 6 מג

dexcel ltd, israel - rivastigmine as hydrogen tartrate - קפסולה קשיחה - rivastigmine as hydrogen tartrate 6 mg - rivastigmine

אקסלון   1.5 מג إسرائيل - العبرية - Ministry of Health

אקסלון 1.5 מג

novartis israel ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 1.5 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.

אקסלון   3 מג إسرائيل - العبرية - Ministry of Health

אקסלון 3 מג

novartis israel ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 3 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.

אקסלון   4.5 מג إسرائيل - العبرية - Ministry of Health

אקסלון 4.5 מג

novartis israel ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 4.5 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementiasymptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.

אקסלון   6 מג إسرائيل - العبرية - Ministry of Health

אקסלון 6 מג

novartis israel ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 6 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.

אלציגמין 1.5 إسرائيل - العبرية - Ministry of Health

אלציגמין 1.5

rafa laboratories ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 1.5 mg - rivastigmine

אלציגמין 3 إسرائيل - العبرية - Ministry of Health

אלציגמין 3

rafa laboratories ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 3 mg - rivastigmine